Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Clinical trial NCT05248997 · COMPLETED

Trial details

NCT number: NCT05248997
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

Start date: 2022-02-17
Primary completion: 2024-03-11
Enrollment: 261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.